Pbx-regulating-protein 1 (Prep1) as a novel transcription factor linking immune system function and metabolism. by Faicchia, Deriggio

1 
 
 
Summary 
 
1. INTRODUCTION 
1.1 Immunometabolism 
1.1.1 Immuno-metabolism, a new branch linking  
            metabolism and immunity ....................................................................................... 3 
1.1.2 Adipose tissue and inflammation ............................................................................... 5 
1.1.3 Inflammation and insulin-resistance .......................................................................... 6 
1.2Immune cells and metabolic alterations 
1.2.1 Macrophages .............................................................................................................. 8 
1.2.2 CD4+ T cells ............................................................................................................... 9 
1.2.3 Regulatory T cells (Treg) ........................................................................................... 10 
1.2.4 CD8+ T cells ............................................................................................................... 11 
1.2.5 B lymphocytes ............................................................................................................ 12 
1.3Tales Family 
1.3.1 Tale proteins ............................................................................................................... 12 
1.3.2 Pbx1 protein ............................................................................................................... 13 
1.3.3 Prep1 protein .............................................................................................................. 14 
1.3.4 Prep1 and metabolic alterations ................................................................................. 15 
 
2. AIM OF STUDY  .......................................................................................................... 17 
 
3. RESULTS 
   3.1 Immunophenotype of Prep1-deficient mice .............................................................. 18 
   3.2 Prep1 deficiency associates with functional  
         impairment of T cell compartment ............................................................................. 19 
   3.3 Biochemical events in T cells from Prep i/+ mice ...................................................... 21 
   3.4 Impaired mitochondrial and glycolytic activity in  
         T cells from Prepi/+ mice ............................................................................................ 23 
   3.5 Increased suppressive activity of Treg cells from Prepi/+ mice .................................. 25 
   3.6 Prep1 deficiency protects from high fat diet-induced  
         metabolic alterations .................................................................................................. 27 
   3.7 Prep1 deficiency protects from high fat diet-induced 
         Inflammation .............................................................................................................. 28 
 
4. DISCUSSION ................................................................................................................ 31 
 
5. MATERIALS AND METHODS 
   5.1 Mice............................................................................................................................ 36 
   5.2 Flow cytometric analysis............................................................................................ 36 
   5.3 T cells purification, cultures and proliferation assays ................................................ 37 
   5.4 Cytokines measurement ............................................................................................. 38 
2 
 
   5.5 Western blots and biochemical analysis .................................................................... 38 
   5.6 Metabolic assays and bioenergetic profiles ................................................................ 38 
   5.7 Glucose tolerance test (GTT ...................................................................................... 39 
   5.8 Statistical analysis ...................................................................................................... 39 
 
6. REFERENCES .............................................................................................................. 40 
3 
 
 
 
1. INTRODUCTION 
 
1.1 Immunometabolism 
1.1.1 Immuno-metabolism, a new branch linking metabolism and immunity 
Metabolism is the phenomenon whereby our body monitors the production, 
maintenance and destruction of biomolecules in order to convey the energy 
necessary to maintain physiological functions. Therefore, biomolecular 
concentrations, within the body, continually vary and undergo specific 
regulation. Changes in food supply and energy expenditure closely regulate 
body fuel stores. Of course, adipose tissue is the most important deposit of body 
reserves. In Western and industrialized countries, sedentary and the excessive 
caloric intake has led to a marked increase in the number of obese subjects; 
obesity indeed, is reaching epidemic proportions in the last few years (Ng et al., 
2014). Moreover it has been associated with a state of low grade chronic 
inflammation, which plays a role in a series of disorders including cancer, 
cardiovascular disease and type 2 diabetes and in the pathogenesis of insulin 
resistance and endothelial dysfunction. Recently, it emerged that the control of 
orexigenic and anorexigenic circuits not only influences body weight regulation 
but also significantly influences other important physiological and dominant 
functions, including immune homeostasis. In particular, many cytokines, 
hormones, neuropeptides and transcription factors play important roles not only 
at the metabolic level, but also at the immunological level (Bruun et al., 2002). 
The excess of adipose tissue, particularly in the visceral compartment, is 
associated with the dysregulation of adipocytokine production, resulting in 
adipocytic hypertrophy, hypoxia and an increase in immune cell infiltration, 
such as macrophages and lymphocytes. The link between obesity and 
inflammation has therefore raised the important issue that obesity-induced 
inflammation plays a pathogenic role in the development and progression of 
disorders such as insulin resistance and type 2 diabetes mellitus (Xu et al., 
2003). In this scenario there is a new study topic which is attracting the attention 
of scientific community: “immunometabolism”. Immunometabolism is the field 
of research that links immunology and metabolism, originally considered two 
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separate and distinct disciplines (Mathis and Shoelson, 2011). However, recent 
scientific evidence and growing interest in this new branch has made it clear that 
metabolic alterations have an impact on immune system functions. Adipose 
tissue releases a number of molecules and factors that mediate, suppress or 
mitigate, the immune response. 
Understanding the relationship between the endocrine and immune functions of 
the adipose tissue and defining the main factors working at the interface 
between metabolism and immunity, may have important implications for the 
development of new therapeutic strategies for obesity and associated diseases. 
Immune cells are highly dynamic in terms of their growth, proliferation, and 
effector functions as they respond to immunological challenges. Different 
immune cells can adopt distinct metabolic assets that allow the cell to balance its 
requirements for energy, molecular biosynthesis, growth and longevity. In this 
context, it is now becoming clear that also intra-cellular metabolism has direct 
roles in regulating immune cell function (Procaccini et al., 2016). The 
coordination of metabolic programs with immune cell fate is a fundamental 
event in the control of immunity. During the course of an immune response, 
immune cells can traverse multiple tissues containing diverse conditions of 
nutrient and oxygen availability. Typically, their activation is accompanied by 
increased expression of effector molecules, an event which is also accompanied 
by extensive and rapid cellular proliferation. Recent studies have revealed the 
fundamental importance of metabolic reprogramming, including dynamic 
regulation of aerobic glycolysis (the Warburg effect), lipid synthesis and 
degradation, and mitochondrial activity, in immune cell activation and 
differentiation and the outcome of immune responses. This process depends 
upon the interplay between the metabolic machinery, immune signaling and 
transcriptional pathways. Malnutrition or hunger directly affect the function of T 
cells by altering the level and type of cellular metabolism. It is also well known 
that energy-demanding processes related to T cell differentiation directly link 
cellular function with energy-generating mode: the critical link between 
metabolism and immunity is indicated by findings that aberrant immune cell 
metabolism not only affects inflammatory responses and adaptive immunity, but 
also contributes to metabolic disorders (Chandra, 1999; Hotamisligil et al., 
2006). 
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 1.1.2 Adipose tissue and inflammation 
Adipose tissue is a well-vascularized and innervated tissue that contains a 
connective tissue matrix and numerous immune cells, including macrophages. 
The white adipose tissue (WAT) is the type of fat in which triglycerides are 
stored and from which lipids are mobilized for systemic use when other tissues 
need energy. WAT is often subdivided into subcutaneous and abdominal 
deposits, whose physiologies can be distinct and whose functions in pathological 
conditions can also be distinct. This is contrasted with brown adipose tissue, 
whose main function is thought to be non-shivering thermogenesis, a process of 
heat production through the uncoupling of oxidative phosphorylation. Originally 
considered as a passive warehouse for energy storage, WAT is now known to 
secrete a variety of substances that help to regulate immune homeostasis (Tilg 
and Moschen, 2006). Adipose tissue is not only a reservoir for energy, but also 
an immune organ (Grant and Dixit, 2015). In the context of obesity, the 
development of insulin resistance is now recognized to be initiated by 
inflammation of the adipose tissue. The first discovery of inflammation in obese 
tissues in the mouse revealed increased levels of the cytokine TNF-α in adipose 
tissue (and in adipocytes themselves) of obese mice compared with lean 
controls. This report was soon followed by a wealth of studies describing the 
inflammatory differences between obese and lean animals as well as humans. It 
is now appreciated that not only TNF-α but an array of inflammatory cytokines 
are increased in obese tissues, including interleukin (IL)-6, IL-1β, CCL2, and 
others (Cawthorn and Sethi, 2007). 
Immune cells in adipose tissue, especially macrophages, have always attracted 
the attention of the scientific community. Both in humans and mice, the number 
of bone marrow macrophages is closely related to obesity and inflammatory 
states. Adipose tissue in obese subjects is characterized by macrophage 
infiltration, which has been shown to be stimulated from the adipocyte 
production of MCP-1 (monocytic chemoattractant), able to attract monocytes 
into the adipose tissue, where they become activated. The recruitment of 
macrophages into adipose tissue is the initial event in obesity-induced 
inflammation and insulin resistance (Kanda et al., 2006). 
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1.1.3 Inflammation and insulin-resistance 
Obesity-induced chronic inflammation is one of the most important mechanisms 
that can lead to the development of insulin resistance and metabolic syndrome. 
Therefore, obesity, inflammation and insulin resistance are not disconnected but 
they are pathological conditions, which are closely related, each other (Asghar 
and Sheikh, 2017). Although a connection between inflammation and diabetes 
was suggested more than a century ago, the evidence that inflammation is an 
important player in the development of insulin resistance came approximately 
20 years ago, when Feingold and Grunfeld observed that administration of the 
proinflammatory cytokine tumor necrosis factor-α (TNF-α) led to increased 
serum glucose concentrations, thus suggesting that hyperglycemia may be 
exacerbated by cytokine overproduction (Grunfeld and Feingold, 1992). 
Figure 1. Immune cells in adipose tissue during obesity. In the lean 
adipose tissue, eosinophils and Th2 cells and Treg cells promote an anti-
inflammatory milieu through the secretion of IL4, IL10 and IL13 
inducing macrophage M2 polarization. In the obese adipose tissue, over 
nutrition leads to bigger adipocyte, leading to the recruitment of different 
immune cells and the development of a pro-inflammatory environment. 
In this context, macrophages are recruited and induced to become pro-
inflammatory M1 macrophages, leading to enhanced immune cells 
activation and increased secretion of pro-inflammatory cytokines.  
(image taken from H.L. Kammoun et al, 2014) 
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However, the first studies that established the concept of obesity-induced 
adipose tissue inflammation were performed by Hotamisligil et al., who showed 
that TNF-α was elevated in obese rodents and that neutralization of TNF-α was 
able to ameliorate insulin resistance (Hotamisligil, 1999). Additionally, mice 
deficient in TNF-α showed improved insulin sensitivity during diet-induced 
obesity. A mechanistic link between inflammatory processes and insulin 
resistance was further established by showing that the signaling pathways 
leading to activation of inhibitor of κB kinase-β (IKK-β) and nuclear factor-κB 
(NF-κB) are stimulated in obesity and insulin resistance (Solinas and Karin, 
2010; Cai et al., 2005). 
Several scientific evidence now supports the idea that pro-inflammatory 
cytokines can cause insulin resistance in adipose tissue, skeletal muscle and 
liver, reducing the signal transduction of insulin. Cytokine sources in insulin-
resistant states are mainly fat and liver, but to a greater extent activated tissue 
macrophages. Chronic inflammation in these tissues could cause localized 
insulin resistance via autocrine/paracrine cytokine signaling and systemic 
insulin resistance via endocrine cytokine signaling all of which contribute to the 
abnormal metabolic state (Pirola and Ferraz, 2017). The proof that an anti-
inflammatory strategy may be successful in the treatment of insulin resistance 
has come from studies using salicylates. Several years ago, it has been shown 
that high doses of salicylates administered to obese mice inhibit NF-κB activity, 
leading to improved insulin sensitivity and glucose metabolism and were able to 
lower glucose levels in diabetic patients, improving glycemic control. The anti-
hyperglycemic and anti-inflammatory effects of salicylates are important 
indications for the link of inflammation to type 2 diabetes (T2D). Another 
therapeutic approach to modulate the immune system involves TZDs 
(thioazolinediones). TZDs are PPAR-γ ligands with well-known insulin-
sensitizing effects in the clinical setting (Hammarstedt et al., 2005). These 
compounds also have potent anti-inflammatory actions that contribute to the 
overall improvement in insulin resistance with type 2 diabetes treatment. In 
addition to TNF-alpha, several clinical studies have been conducted using 
different strategies to inhibit IL-1 signaling. Studies in rodents and humans have 
shown that blockade of IL-1 action results in a modest improvement in glycemic 
control attributable to enhanced B cell function, but insulin sensitivity was not 
increased (McLaughlin et al., 2017). 
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These new findings help to reinforce the idea that obesity increases the risk of 
developing T2D and metabolic syndrome, by modulating immune system 
functions. This finding showing that insulin resistance might result from 
immunological alteration represents a new scientific focus for setting up anti-
inflammatory strategies to modulate the consequences of metabolic alteration, 
such as obesity (Huh et al., 2014). 
 
1.2 Immune cells and metabolic alterations 
As previously mentioned, one of the feature of the inflammatory state of obesity 
is the increased infiltration of immune cells into the metabolic tissues. For 
example, the macrophage population is increased in the adipose tissue of obese 
mice or mice fed a high-fat diet (HFD) compared with lean mice fed normal 
chow, and these cells also contribute to the increased tissue cytokine expression 
(Xu et al., 2003; Weisberg et al., 2003). Although the factors attracting and/or 
activating immune cells in obese tissues are not yet fully understood, what is 
clear is the consensus that metabolic processes, especially obesity and obesity 
related complications, activate both the innate and adaptive arms of the immune 
system. Obesity associated inflammation appears to be caused by infiltration of 
inflammatory immune cells and a parallel loss, or functional reprogramming, of 
immunoregulatory cells. Together, these changes lead to a variety of positive 
feedback pathways that not only sustain chronic inflammation, but also 
contribute to the development of insulin resistance. 
 
1.2.1 Macrophages 
Different subsets of macrophages are involved in obesity-induced adipose tissue 
inflammation. Macrophages that accumulate in the adipose tissues of obese mice 
mainly express genes associated with an M1 or “classically activated” 
macrophage phenotype, whereas adipose tissue macrophages from lean mice 
express genes associated with an M2 or ‘alternatively activated’ macrophage 
phenotype (Lumeng et al., 2007). Both M1-like and M2-like populations express 
F4/80 and CD11b, and the M1-like macrophages also expresses CD11c 
(Lumeng et al., 2007). In the obese state, M1-like macrophages can accumulate 
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lipids, assuming a foamy appearance in the adipose tissue. Stimulation with T 
helper 1 (Th1-type) cytokines, including interferon-γ (IFN-γ), or with bacterial 
products leads to the generation of M1 macrophages(Gordon, 2003). 
Conversely, T helper 2 (Th2-type) cytokines such as IL-4 and IL-13 polarize 
macrophages to the M2 phenotype, which up-regulate IL-10 production and 
downregulate synthesis of pro-inflammatory cytokines. Thus, obesity-induced 
perturbations in the balance between Th1- and Th2-type signals may influence 
the recruitment and activation of macrophages in adipose tissues, thereby 
generating either a pathogenic and inflammatory environment or a non-
inflammatory and protective environment (Figure 1). Tissue macrophages 
respond to changes in the local environment by changing their polarization 
status, and thus, the M1 and M2 classifications are oversimplifications of the 
more dynamic and varied polarization states of macrophages that can be 
observed in vivo. There are several scientific evidence that proinflammatory 
polarized macrophages can cause insulin resistance. In fact, they can secrete 
proinflammatory cytokines that directly reduce insulin sensitivity (Brestoff and 
Artis, 2015). The evidence of this action comes from experiments in which the 
elimination or inactivation of the main inflammatory pathways mediated by 
macrophages have been performed. For example, the elimination of IKK-β, 
JNK1, insulin receptor or fatty acid binding protein 4 (FABP4) in mice leads to 
protective action from insulin resistance induced by obesity (Arkan et al., 2005; 
Mauer et al., 2010; Furuhashi et al., 2008). 
 
1.2.2 CD4+ T cells 
The total number of T cells increases in obesity in the visceral adipose tissue 
(VAT) and in parallel increases their proliferation and infiltration in response to 
specific adipose tissue factors (Gerriets and MacIver NJ, 2014; Schipper et al., 
2012). In addition, it has been shown that one of the T-cell chemoattractors, the 
RANTES factor, is induced in adipocytes after activation by IFN-γ and/or TNF-
α (Kabir et al., 2014). Therefore, obesity-induced factors would contribute both 
quantitatively and qualitatively to changes in T cell populations, leading to 
accumulation of pro-inflammatory molecules in adipose tissues of obese 
subjects. CD4+ T lymphocytes recognize peptide antigens loaded on MHC Class 
II molecules of antigen-presenting cells. CD4+ T naive cells can be divided in 
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differ subtypes of CD4+ T cells, such as Th1, Th2, Th17, and T (Treg) 
regulatory cells. The principal actors of CD4 T cell differentiation are a variety 
of cytokines, including IFN-γ for Th1, IL-4 for Th2, IL-6, and TGF-β for Th17 
and TGF-β for T-cell regulators. Th1 and Th17 cells mediate pro-inflammatory 
reactions, while Th2 and Treg cells contribute to anti-inflammatory responses. 
Th1 cells and Th17 cells are immune cell subsets that play critical roles in the 
onset of autoimmune diseases and tissue inflammatory responses. Th1 cells 
primarily secret IFN-γ which stimulates monocyte differentiation into M1 type 
macrophages. Consistent with the above observations, IFN-γ KO mice, display 
improved insulin sensitivity, accompanied by a decrease in HFD-induced 
adipose tissue inflammation, because of impaired Th1 differentiation (O'Rourke 
et al., 2008). In contrast, it has been proposed that a relative decrease in anti-
inflammatory/regulatory cell types such as Th2 and Treg cells is associated with 
a huge infiltration of circulating monocytes and subsequent M1 polarization in 
obese adipose tissue. 
                   
1.2.3 Regulatory T cells (Treg) 
Regulatory T cells (Treg) cells are a small subset of T cells, usually constituting 
only 5-15% of the peripheral CD4+ T cell compartment in mice and humans 
(Sakaguchi et al., 2008;Thornton and Shevach, 1998). Treg cells are important 
in the control of the inappropriate immune responses that characterize 
autoimmunity and allergy. In general, Treg cells control effector T cell 
responses and also influence the activities of cells of the innate immune 
compartment. These cells, characterized as CD4+ CD25+ Foxp3+, are therefore a 
well known anti-inflammatory T cell subset (Procaccini et al., 2011). The 
proportion of Treg cells among CD4+ T cells is relatively high in adipose tissue 
compared with spleen, lymph nodes, and lung. The number of Treg cells is 
decreased in adipose tissues of obese mice models such as ob/ob, db/db mice 
lacking of leptin and leptin-receptor respectively (Deiuliis et al., 2011). 
Depletion of Treg cells in mice by diphtheria toxin (DT) aggravates adipose 
tissue inflammation and insulin resistance (Bapat et al., 2015). On the other 
hand, expansion of Treg cells in mice induced by IL-2 injection, attenuates 
adipose tissue inflammation and improves insulin sensitivity, in part through IL-
10-mediated suppression of the conventional T cell proliferation. Notably, VAT 
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Treg cells have been shown to display adipose tissue-specific T cell receptor 
(TCR) repertoires compared with splenic Treg cells but the identities of the 
antigens specific to VAT Treg cells remain to be explored. One of the distinct 
characteristics of Treg cells residing in VAT is a high level of PPARγ 
expression as compared  to Treg cells in other tissues (Cipolletta et al., 2012). 
PPARγ KO mice specifically in Foxp3-expressing cells, show a significant 
decrease in the number of VAT Treg cells and a consequent increase in adipose 
tissue inflammation (Hamaguchi et al., 2012). On the other hand, treatment with 
TZD, a PPARγ agonist, induces an increase in VAT Treg cells followed by a 
reduction of inflammation in adipose tissue, indicating an important role of 
PPARγ in the accumulation and phenotype of adipose tissue Treg cells.  
 
1.2.4 CD8+ T cells 
CD8 T cells recognize peptide antigens loaded by MHC class I molecules on 
antigen presenting cells and participate in proinflammatory cytokine secretion 
and cytolysis of target cells. It has been reported that the number of CD8 T cells 
is elevated in obese adipose tissue. Nishimura and collegues have shown that the 
percentage of CD8+ T cells in stromal vascular cells (SVCs) is increased upon 2 
weeks of HFD feeding whereas macrophage infiltration is induced after 6 weeks 
of HFD feeding (Nishimura et al., 2009). Furthermore, elevation of CD44+ 
CD62L+ (effector memory marker) CD8 T cells and a decrease in CD44- 
C62L+naïve CD8+ T cells is observed in obese adipose tissues(Yang et al., 
2010). Interestingly, the presence of CD8+ T cells with a distinct TCR repertoire 
in obese adipose tissue has been reported, suggesting the presence of an adipose 
tissue-specific response of CD8+ T cells during obesity obesity. Consistent with 
the above observation, depletion of CD8 T cells by injection of anti-CD8 
antibody into diet-induced obesity (DIO) mice results in a sharp decrease in the 
levels of pro-inflammatory cytokines such as IL-6 and TNF-α, associated with a 
concomitant increased glucose tolerance and insulin sensitivity, independently 
from obesity (Nishimura et al., 2009). Moreover, in co-culture experiments of 
CD8+ T cells with macrophages, CD8+ T cells have been shown to induce 
macrophage differentiation from monocytes and to sustain pro-inflammatory 
cytokine secretion, confirming the critical role of CD8+ T cells in the control of 
macrophage polarization and activation (Nishimura et al., 2009). 
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1.2.5 B lymphocytes 
 
B cells are key lymphocytes in the adaptive immune response, especially the 
humoral immune response. B cells not only produce antibodies but also may act 
as antigen presenting cells. In early obesity, an increase in the number of 
immunoglobulin G (IgG+ CD19+ B cells) in VAT has been reported, indicating 
accumulation of class switched mature B cells in obese adipose tissues (Winer et 
al., 2011). Confirming a key role of B cells in the control of obesity, B cell 
deficiency has been shown to reduce VAT-resident M1 macrophages and CD8+ 
T cell-mediated IFN-γ expression, leading to an improvement in glucose 
tolerance during obesity. Additionally, transplantation of MHCI- or MHCII- 
deficient B cells suppresses IFN-γ expression in both CD4+ T cells and CD8+ T 
cells in obese mice, indicating that MHC I and MHC II molecules on B cells 
would affect adipose tissue inflammation by modulating T cell activity in 
adipose tissues. Furthermore, IgG produced by B cells induce clearance of 
apoptotic and necrotic debris through antibody-mediated fixation of complement 
proteins involved in the phagocytosis of macrophages. Recently, an adipose 
regulatory B cell population called “Breg” has been reported to play an 
intermediate antiinflammatory role in adipose tissue inflammation via the 
production of IL-10 (Nishimura et al., 2013). Nevertheless, it is necessary to 
delineate more precisely which subtypes of B cells are involved in the adipose 
tissue inflammation and identify the regulatory mechanisms underlying the B 
cell-mediated immune response in adipose tissues during obesity. 
                    
1.3 TALE Family 
 
1.3.1 TALE proteins 
The tri-amino acid loop extension proteins (TALE), best known as transcription 
factors family, are responsible for the regulation of important processes, such as 
growth and differentiation during vertebrate embryogenesis. The genes encoding 
these proteins are highly preserved ancestrally and they are highly conserved in 
both vertebrates and plants, constituting a link in the evolution of the two 
systems (Gehring et al. 1994). TALE proteins have a domain that binds highly 
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preserved DNA sequence of about 60 amino acids called “homeodomain”. This 
region consists of three alpha helixes and an N-terminal arm. Homeodomain 
interacts with DNA through one of the three alpha helix that specifically bind 
certain bases to the major DNA groove. Instead, the N terminal portion binds to 
the bottom of the DNA. In the middle of the first two alpha helix there is an 
extension of three amino acids, virtually represented by proline (P) - tyrosine 
(Y) - proline (P) in position 24-26. This domain has been implicated in 
important protein-protein interactions needed for the fundamental aspects of 
development. The superfamily of TALE proteins consists of two subclasses: 
PBC and MEIS, whose cooperative function is crucial for transcriptional 
regulation. Many players of these two families, has been shown to be of 
fundamental importance to Hox-mediated development programs (Moens and 
Selleri, 2006; Chan et al., 1994). 
 
1.3.2 Pbx1 protein 
Pbx1 (pre-B cell leukemia transcription factor) is an ubiquitous molecule 
belonging to the PBC family. Several studies in the past years have identified 
this proto-oncogene as one of the loci affected by translocation t(1;19), found in 
a large cohort of children affected by pediatric pre-B-cell acute lymphoblastic 
leukemias (Kamps et al., 1990). However, in mice, the individual contribution 
of each member of the PBC family seemed to be different because, while the 
single mutant Pbx1 had a wide range of malformations, the same cannot be said 
forPbx2 and Pbx3 mutants. This evidence suggests an important role for Pbx1 in 
embryonic development. Recent genetic studies indicate the role of TALE 
homeodomain protein Pbx1 in the development and function of pancreatic islets. 
Pbx1, indeed, is required for pancreatic cell growth and differentiation. Pbx1−/− 
embryos exhibit pancreatic hypoplasia and marked defects in exocrine and 
endocrine cell differentiation before death at embryonic day (E) 15 or E16 
(Jonsson et al., 1994). Pbx1 has been shown to play an absolutely non-marginal 
role in pancreatic insulin secretion in mature mice and the absence of its 
regulatory activity leads to inadequate levels of circulating insulin and impaired 
glucose tolerance (Selleri et al., 2001; Kim et al., 2002). In these animals PDX-1 
levels are strongly reduced, indicating that Pbx1 is also important for its 
expression.  
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1.3.3 Prep1 protein 
Pbx-regulating-protein 1 (Prep1) is a 64 kDaubiquitary transcription factor 
mapping on the chromosome 21q.22.3 which plays a key role in early 
development, genomic stability, hematopoiesis. Indeed, Prep1 forms DNA-
independent dimeric complexes with the Pbx homeodomain transcription factor, 
enhancing target specificity and regulatory function (Berthelsen et al., 1998). 
Prep1 could be localized both in cytoplasm and in nucleus and the 
heterodimerization with Pbx1 appears to be essential to translocate Prep1 into 
the nucleus to bind DNA target. Moreover, Prep1 dimerization prevents nuclear 
export and the proteasomal degradation of Pbx1, prolonging its half-life 
(Berthelsen et al., 1999) (Figure 2). Formation of dimeric complex drastically 
increases binding affinity of Prep1/Pbx1 to the DNA and also broadens the 
DNA target selectivity of Pbx1 to include sequences containing the TGACAG 
sequence. Prep1 and Pbx1 can form ternary complexes with PDX-1 to regulate 
somatostatin gene transcription (Goudet et al., 1999). The role of Prep1 has been 
in part clarified by the generation of mutant mice. Nevertheless, Prep1 null 
embryos result in early lethality before gastrulation (E7.5) (Fernandez-Diaz et 
al., 2010). An insertion of a retroviral vector in the first intron of the Prep1 gene 
results in a hypomorphic mutation (Prep1i/i) that exhibits variable penetrance 
and expressivity. Prep1i/iembryos die between E17.5 and P0 and display a 
profound alteration in the hematopoietic development (Ferretti et al., 2006). 
However, a small percentage of the Prep1i/iembryos are born alive and 
subsequently live a normal length-life. The mice escaping embryonic lethality 
show T-cell development anomalies with a decreased number of hematopoietic 
precursors (Penkov et al., 2005). In addition, Prep1i/ifeature an impairment of 
erythropoiesis and angiogenesis accompanied by liver hypoplasia, decreased 
hematocrit, anemia, and delayed erythroid differentiation together with a 
decrease in capillary formation. Prep1 deficiency affects the expression of both 
TALE class partners Pbx and Meis, both required for embryonic (Azcoidia et al., 
2005; Di Martino et al., 2001). 
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1.3.4 Prep1 and metabolic alterations 
Recent scientific evidence has shed light on an important role of Prep1 in 
pancreas development, glucose homeostasis and regulation of insulin activity in 
muscle and liver (Oriente et al., 2008; Oriente et al., 2011). Prep1-hypomorphic 
mice show smaller pancreatic islets but with a normal architecture. However, 
these mice are characterized by hypoplasia of pancreatic insulae, accompanied 
by significantly reduced levels of absolute insulin (basal and post-load). In the 
hypomorphic mice (Prep1i/i) there was also a reduction in pancreatic Pbx1 
expression, underlining the idea that Prep1 could act hierarchically upstream and 
indirectly on the development of the pancreas, by controlling Pbx1 levels. These 
mice exhibit protection against streptozotocin-induced diabetes and increased 
insulin sensitivity with improved ability to metabolize glucose. Prep1 deficiency 
in animal models improves insulin signaling in liver increasing hepatic glycogen 
content and decreasing glucose output and triglyceride levels. Analysis of the 
initial steps in insulin signaling in the Prep1-deficient mouse liver revealed 
increased tyrosine phosphorylation of both insulin receptor and the major 
insulin-receptor-substrate (IRSs) (Oriente et al., 2008; Oriente et al., 2011). 
Taken together, all these data can suggest that Prep1 could be considered a new 
Figure 2.Model of how Prep1 attenuates Meis1a action. Prep1 and 
Pbx1 interaction determines Meis1a levels and the extent of tumor 
formation. Specifically, Prep1 attenuates Meis1a tumorigenic activities 
by squelching Pbx1 from Pbx1–Meis1a complexes, leading to 
proteasome-dependent degradation of Meis1a.  
16 
 
gene involved in the pathogenesis of type 2 diabetes and insulin resistance. In 
agreement with these findings, a recent paper showed that serum triacylglycerols 
and liver expression of fatty acid synthase (FAS) were significantly decreased in 
Prep1 hypomorphic heterozygous (Prep1i/+), as compared with their non-
hypomorphic littermates. Moreover, other studies, showed that despite the 
treatment with a methionine- and choline-deficient diet (MCDD) induced 
steatosis in both Prep1i/+ and non-hypomorphic control mice, the levels of 
alanine aminotransferase, the intracellular triacylglycerol content, the liver 
steatosis, inflammation and necrosis were significantly less evident in 
Prep1i/+mice, indicating that Prep1 silencing can protect mice from MCDD-
induced steatohepatitis (Oriente et al., 2013). 
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2. AIM OF STUDY 
The radical change in the lifestyle of Western countries observed in recent years 
has inevitably promoted the emergence of dysmetabolic conditions. In this 
regard, it has become necessary to identify new lifestyle-enhancing markers, 
possibly acting in tandem, on one side on the resolution of obesity/insulin 
resistance, and on the other side on the immune system functions. As in recent 
years, immunometabolism is becoming a matter of growing interest in the 
scientific community, the identification of possible novel factors, working at the 
interface between these two disciplines, becomes of crucial importance.Prep1 is 
a homeodomain transcription factor involved in the regulation of key processes 
such as organogenesis and major developmental pathways. Since recent 
evidence have highlighted the pathological involvement of the immune system 
in the regulation of altered metabolic conditions, and given the recent findings 
showing that Prep1 inhibition increased insulin sensitivity, protecting from 
streptozotocin-induced diabetes, the purpose of this study is to evaluate the role 
of Prep1 in the control of immune system functions. More specifically, we will 
investigate how and whether Prep1 down-regulation may affect the functional 
activity of the main immune cells, in physiological settings and in condition of 
metabolic pressure. Finally, our ultimate goal will be to identify Prep1 as a 
potential novel therapeutic target for immune-mediated metabolic disorders.  
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3. RESULTS 
 
3.1 Immunophenotype of Prep1-deficient mice 
 
Starting from recent data showing the link between metabolic alterations and the 
immune system functions, and from the previous experimental evidence 
demonstrating that hypomorphic mice for Prep1 are protected from liver 
damage (Oriente et al., 2013), we first measured the secretion of several 
cytokines in the sera of in Prep1i/+ mice by comparing them with those observed 
in their littermate controls (WT mice). We found that Prep1 hypomorphic mice 
displayed a reduced amount of different pro-inflammatory cytokines (IL-6, IL-
1β, IL-17, IFN-γ, MCP-1, MIP-1β and TNF-α) and an increased concentration 
of one of the best characterized anti-inflammatory cytokines, such as IL-10 
(Figure 3A). Next we compared the basal immunophenotype of the spleens of 
Prep1i/+mice and their littermate controls. Flow cytometric analyses revealed no 
significant differences in the spleens of the two groups of mice, in terms of 
percentage of the different immune cells subsets (data not shown).  
However, significant differences were observed in the percentage of immune 
cells infiltrating the liver. Indeed, Prep1i/+mice displayed significant lower 
percentage of CD45+ cells (a common leukocyte antigen) associated with a 
reduction in T cell compartment (CD3+, CD4+ and CD8+ cells) and increased 
percentage of B cells (Figure 3B). 
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Figure 3. Cytokine production and liver immunophenotype of Prep1i/+ mice. (A)The graphs 
show IL-6, IL-1b, IL-17, IFN-γ, MCP-1, MIP-1b, TNF-a and IL-10 production in the sera of 
WT (black columns) and Prep1i/+(green columns) mice. Data are shown as mean ± S.E.M. (n= 8 
mice/group; **p < 0.001, ***p < 0.0001). (B) Cytofluorimetric plots showing ex vivo 
immunophenotype (CD3, CD4, CD8, CD19, CD11b, CD11c, CD14 and NK) of the livers from 
Prep1i/+mice and their control littermates. One representative out of three independent 
experiments. 
 
 
3.2 Prep1 deficiency associates with functional impairment of T cell 
compartment 
 
We next analyzed whether Prep1 inhibition could be associated with a 
functional alteration of T cell responses. To this purpose, we isolated 
splenocytes from both groups of mice (Prep1i/+and WT) and we analyzed their 
proliferative profile. We found a reduced proliferative capability in Prep1i/+ 
mice upon TCR-mediated activation (with anti-CD3, 2C11 mAb) compared to 
WT mice, as indicated by a reduced thymidine incorporation (Figure 4A). In 
accordance with reduced proliferation, T cells from Prep1i/+mice also secreted 
significantly lower levels of proinflammatory cytokines, including IL1-α, IL1-β, 
IL-6, IL-17, IFN-γ, TNF-α, MCP-1, MIP1-α, and MIP1-β in cell culture 
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supernatants with respect to WT mice (Figure 4B). This cytokine profile was 
accompanied by a reduced expression of classical cell surface activation 
markers on CD4+ T cells in Prep1i/+mice. Indeed, the expression of CD25, 
CD54 (ICAM-1), CD49d (VLA-4), CD71 and MHCII was significantly lower in 
T cells of Prep1i/+mice as compared to WT controls (Figure 4C),thus providing 
a clear indication of the possible key role of Prep1 in the control of activation 
and function of the immune system. 
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Figure 4. Analysis of T cell functions in Prep1i/+mice. (A) Proliferative response (evaluated as 
thymidine incorporation) of T lymphocytes isolated from WT (black columns) and 
Prep1i/+(green columns) mice, stimulated or not with anti-CD3 for 48 hours. Data are presented 
as mean ± S.E.M. of three independent experiments (*p < 0.005). (B) Graphs show the secretion 
of IL-1a, IL-1b, IL-6, IL-17, IFN-γ, TNF-a, MCP-1, MIP-1a, in cell supernatant derived from T 
cells isolated from WT (black columns) and Prep1i/+(green columns) mice, stimulated with anti-
CD3 for 48 hours. The data are shown as mean ± S.E.M of three independent experiments (***p 
< 0.0001; **p < 0.001; *p < 0.01). (C) Cytofluorimetric analysis of the expression of the main 
activation markers (CD25, CD54, CD49d, MHCII, CD71, MHC II) expressed by T cells from 
WT (black histogram) and Prep1i/+(green histogram) mice, stimulated with anti-CD3 for 36 
hours. One representative plot out of three independent experiments.  
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3.3 Biochemical events in T cells from Prep1i/+ mice 
In order to identify the molecular mechanism associated with impaired Tcell 
proliferation observed in Prep1i/+mice, we analyzed the biochemical events in 
12 hours cultured splenocytes from both groups of mice, in the presence or 
absence of TCR-mediated stimulation. The substantial amount of ERK1/2 
phosphorylation and the low level of the cell cycle inhibitor p27kip1 indicated the 
high proliferative status of TCR-stimulated T cells from WT mice (Figure 5A). 
Conversely, upon TCR stimulation, T cells from Prep1i/+mice showed a reduced 
activation of ERK1/2 and increased levels of p27kip1, suggesting a possible cell 
cycle arrest in these cells (Figure 5A). Since it has been demonstrated that 
mTOR (mammalian-target-of rapamycin) kinase complex supports 
differentiation and proliferation of T cells (Laplante and Sabatini, 2010; 
Procaccini et al., 2010; Procaccini et al., 2012), we next evaluated its activity 
in terms of phosphorylation of mTOR itself and of its downstream target, the 
ribosomal protein S6. The amount of phosphorylated mTOR in the two groups 
of mice was almost the same, while a significant decrease in S6 phosphorylation 
has been observed in Prep1i/+ T cells, both in basal conditions and upon anti-
CD3 stimulation, thus suggesting a reduced mTOR kinase activity associated 
with impaired proliferation of T cells in those mice where the expression of 
Prep1 was reduced (Figure 5B).  
As we previously shown a reduced production of pro-inflammatory cytokines in 
Prep1i/+ mice, we also analyzed the activity of STAT5, a key element in 
IL2/IL2-Receptor signal transduction, in T cells of both groups of mice. In WT 
mice there was a strong phosphorylation of STAT5 upon TCR engagement, 
while T cells from the Prep1i/+mice showed low levels of p-STAT5 even after 
TCR-mediated stimulation (Figure 5C). In addition, we also found that 
inhibition of Prep1 compromised the phosphorylation of STAT3, another 
downstream molecule involved in inflammatory signaling, both in basal 
conditions and after-TCR-mediated stimulation (Figure 5C).  
Autophagy is the basic catabolic mechanism which ensures cell survival during 
reduced energy availability (ie. starvation) by maintaining cellular energy levels 
(Riffelmacher et al., 2017).Current evidence indicates that a fine tuning of 
autophagy has a major role in enabling differentiation and activation of immune 
cells. Given the functional difference of T cells from WT and Prep1i/+mice, we 
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also analyzed the involvement of the autophagic process in this phenomenon. 
The conversion of microtubule associated protein light chain 3 (LC3-I) into 
LC3II (autophagic flux), a well-known marker of autophagy activation, has been 
analyzed by western blotting in unstimulated and TCR-activated T cells from 
Prep1i/+mice and their littermate controls. As shown in Figure 5D, unstimulated 
splenocytes from Prep1i/+mice displayed significant higher levels of LC3II 
lipidation, when compared to WT mice (Figure 5D). TCR stimulation decreased 
LC3II lipidation both in WT and Prep1i/+mice (Figure 5D).To exclude that the 
observed phenomena might be due to an altered lysosomal proteases 
degradation, we confirmed the involvement of Prep1 inhibition on the 
autophagic flux also in the presence of lysosomal protease inhibitors 
(NH4Cl/leupeptin) (Figure 5D). In this case, we observed that the levels of 
LC3II were always higher in T cells from Prep1i/+ mice, even though TCR 
engagement reduced LC3II lipidation, thus suggesting that impaired activation 
of T cells from these mice might be due to the activation of the autophagic 
pathway. 
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Figure 5. Intracellular pathways altered by Prep1 inhibition in T cells. Western blot 
analysisfor P-ERK 1/2, ERK1/2, p27Kip1 and actin (A), p-mTOR, mTOR, p-S6 and S6 (B), p-
STAT5, STAT5, p-STAT3 and STAT3 (C) in T cells isolated from WT and, Prep1i/+ mice (n= 3 
mice/group), in the presence or absence of anti-CD3 stimulation for 12 hours. One 
representative out of two independent experiments. (D) Immunoblot for LC3I/II normalized on 
actin in T cells isolated from WT and, Prep1i/+ mice, stimulated or not with anti-CD3 for 12 
hours, in the presence or absence of specific lysosomal protease inhibitors (NH4Cl/leupeptin). 
One representative out of two independent experiments. 
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3.4 Impaired mitochondrial and glycolytic activity in T cells from Prep1i/+ 
mice 
It has been recently demonstrated that intracellular metabolism plays a key role 
in controlling immune processes. Particularly, the idea that the mitochondrial 
metabolism is crucial to sustain T cell proliferation/activation is becoming 
increasingly popular (Naik et al., 2011; West et al., 2011; Perl et al., 2004). 
Therefore, in order to investigate whether the alteration of Prep1 may affect the 
bioenergetic profile and the mitochondrial function of T cells, we measured the 
oxygen consumption rate (OCR) (an indicator of oxidative phosphorylation) in 
purified CD4+ T cells in both groups of mice, by cell flux analyzer (Seahorse), 
upon TCR-mediated stimulation (Figure 6A) CD4+T cells from Prep1i/+mice 
showed a reduced OxPhos (oxidative phosphorylation) when compared to 
littermate controls, as indicated by the significant decrease in basal OCR and 
ATP-linked OCR (Figure 6B). The same holds true also for the maximal 
respiratory capacity (MRC) (obtained upon stimulation with carbonyl cyanide-
4-(trifluoromethoxy) phenylhydrazone (FCCP), which again was also 
significantly inhibited in CD4+ T cells from Prep1i/+mice (Figure 6B), thus 
suggesting that functional alteration of T cell compartment associates with a 
reduced mitochondrial activity.  
In addition, to assess whether Prep1 inhibition was also associated with a 
decreased glycolytic capacity (the alternative route used by T cells to generate 
ATP), we also evaluated the extracellular acidification rate (ECAR) (an 
indicator of glycolysis engagement) in the same above mentioned experimental 
conditions. CD4+ T cells from Prep1i/+mice, displayed decreased glycolysis 
both at the baseline (after stimulation with glucose) and under maximal 
conditions (upon oligomycin stimulation) (Figures 6C and 6D). Also the 
glycolytic capacity was reduced in Prep1-deficient mice. Taken together, these 
data suggest that the metabolic pathways (mitochondrial respiration and 
glycolysis), which would sustain T cell activation and proliferation, were 
significantly impaired in the absence of Prep1 activity.   
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Figure 6. Intracellular metabolic alterations induced by Prep1 inhibition in CD4+ T cells. 
(A) O2 consumption rate (OCR), measured in real time, in CD4+ T cells stimulated with anti-
CD3/CD28-microbeads and purified from WT (black circles) and Prep1i/+ mice (green squares). 
OCR was measured under basal conditions and in response to indicated mitochondrial inhibitors: 
oligomycin, carbonylcyanide-4- (trifluoromethoxy)-phenylhydrazone (FCCP), Antimycin A and 
Rotenone (Ant/Rot), using an XFe-96 Extracellular Flux Analyzer. One representative out of 
two independent experiments. The data are shown as mean ± S.E.M. of triplicates. (B) Indices of 
mitochondrial respiratory function: basal OCR (before addition of oligomycin), ATP-linked 
OCR (calculated as the difference of basal rate and oligomycin rate), maximal respiration 
(calculated as the difference of FCCP rate and antimycin/rotenone rate) were calculated from the 
kinetic profiles of anti-CD3/CD28-stimulated CD4+ T cells from WT (black columns) and 
Prep1i/+ (green columns) mice. Data are expressed as mean ± S.E.M. of three measurements, 
each of them in triplicates (*p< 0.01). (C) Extracellular acidification rate (ECAR), measured in 
real time, in CD4+ T cells stimulated with anti-CD3/CD28-microbeads and purified from WT 
(black circles) and Prep1i/+ mice (green squares). ECAR was measured under basal conditions 
and in response to glucose, oligomycin and 2-DG. One representative out of two independent 
experiments. The data are shown as mean ± S.E.M. of triplicates. (D) Indices of glycolytic 
pathway activation: basal ECAR (in the presence of glucose), maximal ECAR (after oligomycin 
injection) and glycolytic capacity (calculated as the difference of oligomycin-induced ECA and 
2-DG-induced ECAR) were calculated from the kinetic profiles of anti-CD3/CD28-stimulated 
CD4+ T cells from WT (black columns) and Prep1i/+ (green columns) mice. Data are expressed 
as mean ± S.E.M. of three measurements, each of them in triplicates (**p< 0.001).  
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3.5 Increased suppressive activity of Treg cells from Prep1i/+ mice 
In order to understand whether functional alterations of conventional T cells 
(Tconv) from hypomorphic mice (Prep1i/+) were counterbalanced by an 
increased activity of regulatory T cell compartment (CD4+CD25highFoxP3+), we 
analyzed this specific cell subset in both groups of mice. Ex vivo analyses 
revealed that Prep1i/+mice had a higher percentage of CD4+FoxP3+ than that 
observed in WT mice (Figure 7A). Moreover Treg cells from Prep1i/+mice 
showed an enhanced in vivo proliferative profile, as testified by the increased 
expression of the nuclear proliferation antigen (PCNA) as compared to Treg 
cells from control mice (Figure 7A). Since it has been previously shown that 
mTOR kinase plays a key role in the metabolic control of Treg cell 
responsiveness (Procaccini et al., 2010), we also analyzed the phosphorylation 
of the ribosomal protein S6, as readout of mTOR kinetic activity, in Treg cells 
of both experimental groups. We found that the higher proliferative rate of Treg 
cells in Prep1i/+mice associated with increased mTOR engagement (Figure 7A), 
as suggested by the increased phosphorylation of S6. It is now well accepted 
that one of the prominent features of Treg cells is represented by their strong 
proliferative capacity in vivo (Vukmanovic-Stejic et al., 2006), despite they are 
anergic to in vitro TCR-mediated stimulation (Li et al., 2005), a condition that 
associates with an optimal suppressive activity. Here we found that, Treg cells 
from Prep1i/+mice were able to suppress the proliferation of autologous 
CD4+CD25-FoxP3- T cells (Tconv) in co-culture assays, more efficiently than 
Treg cells from WT mice (Fig. 7B). In addition, in Prep1i/+ mice, Treg cells 
showed not only a greater ability to suppress Tconv proliferation, but also an 
enhanced ability to inhibit proinflammatory cytokines secretion by Tconv cells. 
As shown in Figure 7C, IL-6, IL-12, IL-17, IFN-γ produced by Tconv cells were 
better inhibited by Treg cells from Prep1i/+ mice than by Treg cells from 
littermate controls in co-culture experiments (Figure 7C). 
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Figure 7. Treg cell frequency and function in Prep1i/+mice. (A) Cytofluorimetric plots 
showing the percentage of CD4+FoxP3+ cells (Treg), PCNA and p-S6 expression in Treg cells 
from the spleens of WT and Prep1i/+ mice (one representative out of three independent 
experiments). (B) In vitro proliferation of purified Tconv, Treg cells and of both cell types in co-
culture (at the ratio of 1:1) from WT and Prep1i/+ mice upon anti-CD3/CD28 mAb stimulation. 
Data are shown as mean ± S.E.M (one representative out of two independent experiments, each 
of them performed on a pool of 3 mice/group, **p< 0.001). (C) Fold inhibition of Tconv 
proliferation and IFN-γ, TNF-a, IL-6, MIP-1a, MCP-1 and IL-1b production (D) by Tconv cells 
purified from WT (black column) and Prep1i/+ (green column) mice in co-culture with 
autologous Treg upon anti-CD3/CD28 mAb stimulation. Data are shown as mean ± S.E.M (one 
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representative out of two independent experiments, each of them consisting of a pool of 3 
mice/group, *p< 0.01; **p< 0.001). 
 
                      
 3.6 Prep1 deficiency protects from high fat diet-induced alterations 
To evaluate the role of Prep1 in the protection of liver inflammation and 
metabolic disorders during a condition of metabolic stress, Prep1-deficient mice 
were fed with a high-calorie diet (HFD). The mice were followed for 18 weeks 
and their weight gain has been evaluated over time. We found that Prep1i/+mice 
showed a lower weight gain as compared to WT control mice, when feeding 
with a HFD (Figure 8A).  
In line with these findings, we also found lower levels of serum triglycerides 
(TG) (Figure 8B) in Prep1i/+mice fed with HFD versus WT mice group. Since 
HFD has been associated with impaired glucose tolerance and type 2 diabetes 
development, we next evaluated the effect of the Prep1 deficiency on glucose 
tolerance. WT mice fed a HFD displayed glucose intolerance compared with 
Prep1i/+mice, which showed a significant improvement in glucose tolerance 
(Figure 6C). These data suggest that Prep1 deficiency may play a protecting role 
from the development of glucose-associated abnormalities and the pathological 
fat accumulation observed during HFD. 
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Figure 8. Metabolic alteration of Prep1i/+ mice undergoing a HFD. (A) body weight (in 
grams) of WT and Prep1i/+ mice fed with a high fat diet (HFD), followed for 18 weeks. Data are 
shown as mean ± S.E.M (n = 4 mice for HFD, *p< 0.01). (B) Serum triglyceride content in WT 
(black columns) and Prep1i/+ mice (green columns) fed with a HFD for 18 weeks. Data are 
shown as mean ± S.E.M (n = 4 mice/group for HFD, *p< 0.01). (C) Glucose tolerance test 
(GTT) (panel) performed in WT and Prep1i/+mice fed with HFD at week 18. The blood glucose 
values in milligrams per deciliter are shown as mean ± S.E.M (n= 4 mice/group for HFD, *p< 
0.01; **p< 0.001). 
 
 
 
3.7 Prep1 deficiency protects from high fat diet-induced inflammation 
Since the immune system has been shown to play a central role in the 
pathogenesis of obesity and its-associated alterations, we also analyzed changes 
in liver inflammation caused by Prep1 deficiency upon HFD feeding. First, we 
found a decreased percentage in T cell compartment (CD3+, CD4+, CD8+) 
infiltrating the liver of Prep1hypomorphicas compared to WT littermate controls 
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(Figure 9A) and a tendency to increase the percentage of B cells (CD19+). 
Moreover a decreased accumulation of macrophages has been detected in the 
liver of Prep1i/+mice fed a HFD, as indicated by the reduced percentage of 
CD11c+ and CD11b+ cells (macrophage markers) (Figure 9A), whereas no 
significant differences have been detected in CD14+ and NK cells, between the 
two groups of mice.  
The reduced inflammatory infiltrates observed in the liver of Prep1i/+ mice 
undergoing a HFD, possibly responsible for the protection to liver steatosis, 
were accompanied by an increased percentage of Treg cells, which also 
exhibited a higher proliferative profile (increased positivity for PCNA) sustained 
by a greater mTOR activation (as evidenced by increased phosphorylation of 
ribosomal protein S6) (Figure 9C). Finally, the anti-inflammatory phenotype 
observed in Prep1i/+mice, has been also confirmed by the findings showing a 
reduced secretion of pro-inflammatory cytokines (IFN-γ, TNF-α, IL-17) and 
increased production of anti-inflammatory cytokines (such as IL-10) in the sera 
of these mice, feeding a HFD, as compared to WT mice (Figure 9C). Taken 
together, these data suggest a potential protective role exerted by Prep1 
deficiency in immune cells during metabolic disorders. 
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Figure 9. Hepatic inflammation and liver immunophenotype of Prep1i/+ mice upon HFD. 
(A) Cytofluorimetric immunephenotype (CD3, CD4, CD8, CD19, CD11b, CD11c, CD14, NK) 
of livers from WT (black columns) and Prep1i/+(green columns) mice undergoing a HFD (one 
representative out of three mice/group). Data are shown as mean ± S.E.M. (n= 3 mice/group, 
*p< 0.01).(B) Flow cytometric plots showing the percentage of CD4+FoxP3+ cells (Treg) and the 
expression of PCNA and p-S6 in Treg cells from the liver of WT and Prep1i/+ mice undergoing 
a HFD (one representative out of three mice/group). (C) Serum levels of IFNγ, TNF-α, IL-17, 
IL-10 WT (black columns) and Prep1i/+(green columns) mice fed with a HFD. Data are shown 
as mean ± S.E.M. (n= 4 mice/group; *p  <  0.01). 
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4. DISCUSSION 
Immuno-metabolism is an emerging field of investigation working at the 
interface between historically distinct disciplines: immunology and metabolism 
(Mathis and Shoelson, 2011). Metabolic abnormalities are characterized by a 
strong increase in the secretion of pro-inflammatory cytokines that favor the 
migration of inflammatory cells from the periphery to the inflammatory tissues. 
On the contrary, inflammation associated with metabolic disorders is 
accompanied by a drastic decrease in the number and/or in the function of 
regulatory T cells (Treg cells), a specific cell subset that control immune 
tolerance. In this context, the identification of genes and molecular mechanisms 
involved in the susceptibility and pathogenesis of metabolic disorders is 
becoming crucial. However, the identity of the genes and factors influencing the 
risk of inflammation, working on immune cell functions, have been only 
partially discovered and described, so far. In this thesis, we identified a new 
player, whose modulation is able to improve both the metabolic and the immune 
system functions. Specifically, we found that the homeodomain Prep1 
transcription factor is able to control liver inflammation and insulin resistance 
by acting on different immune cell subsets, modulating their functions. It has 
been observed that Prep1 down-regulation is able to reduce the expansion, 
activation and pro-inflammatory cytokines production by T lymphocytes, both 
in physiological settings and during a condition of metabolic pressure, such as 
high fat diet (HFD). Recently, Oriente and colleagues have demonstrated that 
Prep1-ipomorphic mice (Prep1i/+, characterized by reduced expression of the 
functional protein Prep1) displayed a peculiar phenotype characterized by an 
increased insulin sensitivity in skeletal muscle accompanied by protection from 
streptozotocin-induced diabetes (Oriente et al., 2008). In addition, mice 
expressing a reduced percentage of Prep1 appeared to be protected from 
triglycerides (TG) accumulation and hepatotoxic damage, caused by inadequate 
methionine/choline diet (MCDD) (Oriente et al., 2013).  
In the present study, we show that Prep1i/+ mice are characterized by a general 
anti-inflammatory condition, in which we found decreased activity of 
conventional T lymphocytes (Tconv) and an increased regulatory activity 
exerted by regulatory T cells (Treg). In line with this assumption, lower levels of 
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the major proinflammatory cytokines have been detected in the sera of Prep1i/+ 
mice when compared with those found in WT control mice. In particular, 
Prep1i/+ mice exhibited a reduced secretion of IL-1β, IL-6, IL-17, TNF-α, IFN-
γ, MCP-1, MIP1-β in line with recent findings showing that pro-inflammatory 
cytokines can be considered as co-inducers of insulin resistance.  
Indeed, it has been widely demonstrated that recombinant TNF-α administration 
decreases insulin sensitivity (Hotamisligil and Spiegelman, 1994; Kern et al., 
1995). In addition, we found a decreased secretion of the chemotactic monocytic 
factor-1 (MCP-1) (Wu et al., 2007), thus supporting the hypothesis that reduced 
release of proinflammatory cytokines in the microenvironment does not sustain 
the generation of a chemiotactic gradient responsible for the migration of 
immune cells into inflamed tissues. In contrast, Prep1 inhibition induced 
significantly higher levels of IL-10, one of the most representative anti-
inflammatory cytokine. 
Furthermore, we also showed that Prep1i/+ mice exhibited a reduced 
accumulation of immune cells in the liver, as compared to WT animals and this 
reduction mainly affects T cell compartment. Our data, therefore, could give to 
Prep1 a very important role in the control of T cell fate, function and 
recruitment, and reinforce the notion that T cells are key components in the 
progression of inflammatory condition associated with metabolic alterations. 
Indeed, the decrease in their number and/or function relieves adipose tissue 
inflammation and alleviates insulin resistance in obese mice. Therefore, it is 
clear that the imbalance between the effector T cells and regulatory T cells in 
favor of the former is able to affect metabolic functions, prolonging and 
intensifying the inflammatory state in dysmetabolic syndromes. A clear 
beneficial role in metabolic alterations is covered by Treg cells; in fact several 
scientific papers have shown that Treg cells reduce adipose tissue inflammation 
and insulin resistance (Feuerer et al., 2009; Winer et al., 2009). We then 
wondered whether Prep1 inhibition could affect the functional activity of 
immune cells, and we mainly focused our attention on T cell compartment. We 
found that T cells isolated from Prep1i/+mice exhibited a significantly reduced 
proliferative capacity as compared to their littermate controls, together with an 
impaired capability to secrete pro-inflammatory cytokines in cell culture 
supernatants. The same trend has been observed for the main surface markers 
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expressed by activated T cells, (such as IL-25, ICAM-1, VLA-4 and MHC II), 
as their induction resulted strongly compromised by inhibition of Prep1 activity.  
Therefore we could speculate that Prep1 deficiency renders T cells   
hyporesponsive to TCR-mediated stimulation, thus representing a possible target 
to modulate T cell activity. The protective role provided by Prep1 inhibition is 
further demonstrated by the increased proliferative capacity and suppressive 
activity of Treg cells isolated from the Prep1i/+mice, supported by a prominent 
activation of the mTOR pathway.  
To get insight on the possible biochemical events associated with altered T cell 
functions in Prep1i/+mice, we analyzed the main pathways involved in cell cycle 
progression, proliferation, inflammatory signal transduction and autophagy. We 
found a decreased phosphorylation of ERK1/2 and an increased accumulation of 
p27Kip1. This negative cell cycle regulator has been shown to play a central role 
in the block of T cell clonal expansion, being therefore crucial for induction of 
anergy, determined by blockade of costimulatory pathways (Boussiotis et al., 
2000; Rowell et al., 2005). In parallel, T cells from Prep1i/+ mice displayed a 
compromised activation of the mTOR pathway, which we have previously 
demonstrated to be crucial for the control of T cell differentiation and 
proliferation (Procaccini et al., 2010; Procaccini et al., 2012). mTOR, indeed, 
has been shown to integrate different extracellular signals by acting as a nutrient 
availability sensor, able to determine the quality of T cell activation and 
cytokine production. In this context, the reduced expression of activation 
markers and the decreased production of pro-inflammatory cytokines in T cells 
from Prep1i/+ mice could be partly due to the inhibition of mTOR kinase 
activity. These results are also in line with recent evidence showing that 
inhibition of mTOR decreases in vitro adipogenesis and shows anti-obesity 
effects in mice fed a HFD, lowering leptin and insulin levels and altering T cells 
functions (Chang et al., 2009), similarly to what has been observed in 
Prep1i/+mice. 
In addition, here we also provide evidence that Prep1 inhibition in T cells 
increases the autophagic process. Recent genetic and functional studies have 
shown that autophagy is an anti-inflammatory mechanism, as it dampens 
inflammasome activation and its absence (ATG 16L1 null mice) has been 
associated with increased production of IL- 1β and IL-18 in a mouse model of 
Crohn's disease (Saitoh et al., 2008). In light of these results, the sustained 
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activation of autophagy observed in T cells from Prep1i/+mice is in line with 
their impaired proliferation and their switch towards an anti-inflammatory 
phenotype. 
Recent reports have recently demonstrated that T cell function is governed by 
their specific metabolic requirements (Procaccini et al., 2016). Since Prep1 
inhibition strongly affected T cell functional activity and since it has been 
shown that dysregulated mitochondrial activity could lead to aberrant T cell 
development (Naik et al., 2011; West et al., 2011; Perl et al., 2004), we also 
assessed the impact of Prep1 inhibition on the metabolic machinery governing T 
cell growth and function. More specifically, we analyzed the mitochondrial 
respiration and the activation of the glycolytic pathway in T cells from Prep1i/+ 
mice and their littermate controls. Both these energy-producing pathways were 
impaired in the absence of Prep1 and a particular reduction has been observed 
for the glycolytic engagement. These findings demonstrate that Prep1 down-
regulation, in mice, is able to modulate T cell function, by reducing the 
engagement of metabolic pathways. Therefore the manipulation of specific T 
cell metabolic routes or of the autophagic process, induced by Prep1 inhibition, 
may represent an attractive target for the development of new therapeutic 
approaches for all those diseases characterized by the hyperactivation of the 
immune system.  
Since it has been recently described that conditions of metabolic pressure (such 
as obesity or type 2 diabetes) can affect immune system functions, we have next 
investigated the role of Prep1 and of its inhibition on the regulation of immune 
processes in mice undergoing a hypercaloric diet (high fat diet, HFD), which 
induces obesity, insulin resistance and liver inflammation. We evaluated 
different parameters associated with dysmetabolic conditions (glucose tolerance 
test, body weight, TG content and inflammatory infiltrates in liver) in 
Prep1i/+and age-matched WT mice fed a HFD. Prep1i/+mice showed a reduced 
ability to gain weight overtime, upon HFD. Since obesity is a risk factor for the 
development of insulin resistance (Esser et al., 2014), the reduced body weight 
obtained through Prep1 inhibition could represent an important tool for 
prevention of obesity and for the treatment of type 2 diabetes. The reduced body 
weight gain observed in Prep1i/+mice also associated with an improvement in 
glucose tolerance. All these events have been also associated with a reduced 
liver inflammation, suggested by a strong reduction of immune cells infiltrating 
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the liver, especially those cells belonging to T-compartment (CD4+ and 
CD8+cells). Recruitment of immune cells in adipose tissue and/or liver is an 
important step in the development of insulin resistance during obesity induced 
by a high calorie diet. In light of these considerations, our findings in 
Prep1i/+mice could suggest that targeting Prep1 might induce an improvement 
of dysmetabolic alterations, protecting against liver inflammation and altered 
glucose tolerance. 
Our data are in agreement with recent findings showing that anti-inflammatory 
approaches (i.e. IL-1R blockade, NF-κB pathway inhibition with salicylated 
derivatives) aimed at targeting specific pro-inflammatory pathways, represent 
useful tools for improving parameters of glucose control, thus reducing the risk 
of systemic inflammation (Ruan et al., 2009; Nath et al., 2009; Youssef et al., 
2002 Zhang e Markovic-Plese, 2008).  
In conclusion, our findings have potential therapeutic implications: Prep1 could 
possibly provide a new platform for potential therapeutic manipulation of the 
immune system functions in order to control the progression of metabolic 
disorders, such as obesity and type 2 diabetes. This is an hypothesis worth 
testing in future studies.  
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5. MATERIALS AND METHODS 
 
5.1 Mice 
Prep1-targeted mice were generated by gene trapping by Lexicon Genetics (The 
Woodlands, TX, USA). The general phenotype of these mice has been 
previously described (Ferretti et al., 2006). In the experiments reported in this 
paper, Prep1i/+ mice were backcrossed with wild-type (WT) C57BL/6J mice for 
4 generations. All animal handling conformed to regulations of the Ethics 
Committee on Animal Use of H. S. Raffaele (IACUC permission number 207).  
Hepatic tissue samples were collected rapidly from 8- to 10-week-old male 
C57BL/6-SV129 mice. Tissues were snap-frozen in liquid nitrogen and stored at 
−80°C for subsequent western blotting and real-time RT-PCR analysis, as 
previously described (Oriente et al., 2011; Oriente et al., 2013). All animals 
were kept in temperature and humidity controlled rooms, in a 12/12 h light/dark 
cycle, with lights on from 7:00 A.M. to 7:00 P.M. Food and water were 
provided ad libitum. All the experiments were performed in 8-10-weeks-old 
animals. The blood for serum biochemistry evaluation was collected with an 
intracardiac method, allowed to clot at room temperature and centrifuged for 10 
min; the serum was then separated for shipment. Quantitative analysis of serum 
TG was performed with an ABX Pentra400 clinical chemistry analyzer (ABX-
Horiba, Montpellier, France) according to the manufacturer’s instructions. For 
the diet experiments, six to eight weeks old mice were fed a High fat diet (HFD) 
or a standard diet (SD) [60% kcal from fat or 10% kcal from fat, respectively; 
Research Diets, Brunswick, NJ) for different time periods up to 28 weeks. Body 
weight was recorded weekly. 
 
5.2 Flow cytometric analysis 
FITC-conjugated mAbs to CD4, CD11c, MHCII, NK, CD71, CD127; PE-
conjugated mAbs to CD8, CD14, VLA-4 (CD49d), ICAM-1 (CD54); Cy5 
conjugated mAbs to CD3, CD11b; and allophycocyanin-conjugated mAbs to 
CD45, CD25 were all purchased from BD Biosciences-Pharmingen, while 
allophycocyanin-conjugated mAbs to CD19 was purchased from Miltenyibiotec. 
Anti-FoxP3 (eBiosciences), PCNA (Chemicon International) and phosphor-S6 
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(Cell Signaling) antibodies have been used for intracellular staining, according 
to manufacturer’s instructions. Mouse livers and spleen were dissociated into 
single-cell suspensions with gentleMACSDissociators (Miltenyibiotec) 
according to the manufacturer’s instructions. Isolated spleens and livers were 
then prepared for flow cytometry by incubating cells with the appropriate Abs or 
control isotype–matched Abs followed by PBS washes. Flow cytometry 
experiments were performed with a FACSCanto (Becton-Dickinson, San Diego, 
CA) and analyzed by Flow-Jo software (Tree Star Inc., Ashland, OR). 
 
5.3 T cells purification, cultures and proliferation assay 
Spleen cells were obtained from both strain of mice, dissociated into single-cell 
suspension, and cultured for proliferation assays in flat bottomed, 96- well 
microtiter plates (Falcon BD) at a density of 5 × 105 viable cells per well in a 
total volume of 200 μl RPMI-1640 medium (Invitrogen Corp.) supplemented 
with 2% FCS (Invitrogen Corp.), 2 mM L-glutamine (Invitrogen Corp.), 0.1 mM 
nonessential amino acids (Invitrogen Corp.), 1 mM sodium pyruvate (Invitrogen 
Corp.), 50 μM 2 mercaptoethanol (Sigma-Aldrich), and 100 U/ml penicillin and 
100 μg/ml streptomycin (Invitrogen Corp.). Cells were cultured at 37°C in 100% 
humidity and 5% CO2 in the presence or absence of either mouse anti-
CD3/CD28 beads (Invitrogen Dynal) (0.5 bead/cell; 5 × 104 cells/well) in the 
case of highly purified T cells or with soluble anti- CD3 mAb stimulation 
(2C11, 0.5 μg/ml final concentration; BD Biosciences – Pharmingen) in the case 
of spleen-derived lymphocytes, being co-stimulation provided by the antigen-
presenting cells (B cells) present in the assay.  
Mouse conventional (Tconv) and regulatory T cells (Treg) were isolated with 
the Regulatory T Cell Isolation Kit (MiltenyiBiotec, Gladbach, Germany) and 
by AutomacsProeparator (MiltenyiBiotec) or by high-performance cell sorting 
(MoFlo, Dako). Cells were then cultured and stimulated as previously 
mentioned. The Treg:Tconv ratio in the suppression experiments was 1:1. After 
48 hours cells were incubated for an additional 16 hours with 0.5 μCi/well of 
[3H] thymidine (Amersham Pharmacia Biotech), harvested on glassfiber filters 
using a Tomtec (Orange) 96-well cell harvester, and counted in a 1205 Betaplate 
liquid scintillation counter (Wallac). Results obtained from triplicate cultures are 
expressed as mean c.p.m. ± S.E.M. 
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5.4 Cytokines measurement 
Quantitative analysis IL-1α/β, IL-6, IL-17, INF-γ, monocyte chemoattractant 
protein 1 (MCP-1), macrophage inflammatory protein 1-alpha/beta (MIP-1 α/β), 
TNF-α, IL-10 on sera and cell supernatants were performed using the Bio-Plex 
multiplex Mouse Cytokine and Growth factors kit (Bio-Rad, CA, USA) 
according to the manufacturer’s protocol. 
 
5.5 Western blots and biochemical analyses 
Total cell lysates and western blot analysis were performed as previously 
described (De Rosa et al., 2007). The antibodies used were the following: anti-
p27Kip-1, anti-phospho-mTOR, anti-mTOR, anti-phospho-S6, anti-S6, anti-
phospho-STAT5, anti-STAT5, anti-phospho-STAT3, anti-STAT3, anti-LC3B 
(all from Cell Signaling Technology, Beverly, MA); anti-ERK1/2, and anti-
phospho-ERK1/2 (from Santa Cruz Biotechnology Inc., Santa Cruz, CA). The 
filters were also probed with a anti-actin antibody (Sigma) to normalize for the 
amount of loaded protein. All filters were quantified by densitometric analysis 
of the bands utilizing the program ScionImage (version 1.63 for Mac; Scion 
Corp. Inc.) 
 
5.6 Metabolic assays and bioenergetic profiles 
The metabolic profile has been evaluated in 12 hours-cultured purified T cells 
from Prep1i/+mice and their littermate controls, in the presence anti-CD3/CD28 
stimulation. Real-time measurements of oxygen consumption rate (OCR) and 
extracellular acidification rate (ECAR) were made using an XF-96 Extracellular 
Flux Analyzer (Seahorse Bioscience). Cells were plated in XF-96 plates 
(seahorse Bioscience) at the concentration of 2 x 105 cells/well and cultured for 
12h in RPMI-1640 medium supplemented with 5% FBS serum. OCR was 
measured in XF media (non-buffered DMEM medium, containing 10 mM 
glucose, 2 mM L-glutamin, and 1 mM sodium pyruvate), under basal conditions 
and in response to 5 μM oligomycin, 1.5 μM of carbonylcyanide-4- 
(trifluoromethoxy)-phenylhydrazone (FCCP) and 1 μM of Antimycin and 
Rotenone (all from Sigma Aldrich). Indices of mitochondrial respiratory 
39 
 
function were calculated from OCR profile: basal OCR (before addition of 
oligomycin), ATP-linked OCR (calculated as the difference between basal OCR 
rate and oligomycin-induced OCR rate) and maximal OCR (calculated as the 
difference of FCCP rate and antimycin + rotenone rate). ECAR was measured in 
XF media in basal condition and in response to 10 mM glucose (from Sigma 
Aldrich). Experiments with the Seahorse system were done with the following 
assay conditions: 3 min mixture; 3 minutes wait; and 3 min measurement. Data 
are expressed as mean ±S.E.M.  
 
5.7 Glucose tolerance test (GTT)  
For glucose and insulin tolerance tests, mice were fasted overnight and then 
were injected with glucose (2 g·kg of body weight−1) intraperitoneally. Venous 
blood was drawn by tail clipping at 0, 15, 30, 45, 60, 90, and 120 min without 
reclipping of the tails. Glucose levels were measured with an Accu-Chek 
glucose meter (Roche, Mannheim, Germany).  
 
5.8 Statistical analysis 
The unpaired t-test two tails or the Mann Whitney U test were used for unrelated 
two-group analyses, using GraphPad. For HFD experiments (body weight, 
serum TG, HLD, LDL, AST, ALT, GTT, ITT), two way Anova test was used to 
compare the mean differences between the different groups, followed by Sidak’s 
multiple comparison tests. Results are expressed as mean ± S.E.M. P values < 
0.05 were considered statistically significant. 
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